Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany

This publication has 9 references indexed in Scilit:

• Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens
  Antimicrobial Agents and Chemotherapy, 1989
• Ceftibuten (7432-S, SCH 39720): Comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines
  European Journal of Clinical Microbiology & Infectious Diseases, 1988
• Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin
  Antimicrobial Agents and Chemotherapy, 1988
• In-vitro antimicrobial activity of 7432-S (SCH39720) against commonly isolated respiratory tract pathogens
  Journal of Antimicrobial Chemotherapy, 1988
• Phase I Clinical Studies of 7432‐S, a New Oral Cephalosporin: Safety and Pharmacokinetics
  The Journal of Clinical Pharmacology, 1988
• Novel R-factor borne β-lactamase of Escherichia coli confering resistance to cephalosporins
  Infection, 1987
• Synthesis and biological properties of 7.BETA.-((Z)-2-(2-amino-4-thiazolyl)-4-carboxy-2-butenoylamino)-3-cephem-4-carboxylic acid (7432-S), a new oral cephem antibiotic.
  The Journal of Antibiotics, 1987
• Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency
  Antimicrobial Agents and Chemotherapy, 1986
• In vitro evaluation of cefixime (FK027, FR17027, CL284635): Spectrum against recent clinical isolates, comparative antimicrobial activity, β-lactamase stability, and preliminary susceptibility testing criteria
  Diagnostic Microbiology and Infectious Disease, 1986